B
14.63
-0.13 (-0.88%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Biohaven Ltd. | 看跌 | 看跌 |
AIStockmoo 评分
3.3
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 3.25 |
|
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 11.96% |
| 机构持股比例 | 90.75% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Suvretta Capital Management, Llc | 31 Dec 2024 | 5,620,271 |
| Bellevue Group Ag | 31 Dec 2024 | 2,040,853 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 60.00 (BTIG, 310.12%) | 购买 |
| 中 | 52.00 (255.43%) | |
| 低 | 30.00 (HC Wainwright & Co., 105.06%) | 购买 |
| 平均值 | 50.00 (241.76%) | |
| 总计 | 7 购买 | |
| 平均价格@调整类型 | 13.86 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 19 Aug 2025 | 60.00 (310.12%) | 购买 | 15.25 |
| B of A Securities | 12 Aug 2025 | 49.00 (234.93%) | 购买 | 13.47 |
| Baird | 12 Aug 2025 | 52.00 (255.43%) | 购买 | 13.47 |
| HC Wainwright & Co. | 12 Aug 2025 | 30.00 (105.06%) | 购买 | 13.47 |
| Leerink Partners | 12 Aug 2025 | 50.00 (241.76%) | 购买 | 13.47 |
| Morgan Stanley | 12 Aug 2025 | 54.00 (269.10%) | 购买 | 13.47 |
| JP Morgan | 18 Jun 2025 | 55.00 (275.94%) | 购买 | 14.39 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合